Spin-out DexLeChem is among the first startup companies to be chosen by Bayer Pharma as a strategic partner

Monday, 23. June 2014

Foto © Bayer HealthCare

The high-tech startup DexLeChem has rent its own laboratory and office space in this first life-science centre for entrepreneurship in Berlin. On the site of former Schering company, Bayer Pharma has founded „CoLaborator“, a new business incubator for chemical and biotechnology companies.

„Because of the close vicinity to other pharmaceutical and chemical companies, the CoLaborator is a perfect location for networking between innovators, industry and economy“, says Sonja Jost, CEO and head of R&D of DexLeChem.

Sonja Jost is former research associate of Prof. Reinhard Schomäcker, who is a member of UniCat’s Executive Board. She invented a new sustainable process where homogeneous chiral catalysts can be reused - several times and unmodified. This invention was the beginning of DexLeChem.

Photo: Andreas Fibig, Prof. Dr. Stefan Jaroch, Sonja Jost, Robert Pytela, Prof. Dr. Andreas Busch, Berlin Major Klaus Wowereit (from left to right).